ArticleImmuno-oncology technology2023

Corrigendum to "Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies": [Immuno-Oncology and Technology 10 (2023) 100394].

J R Cox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.